Trexquant Investment LP Purchases Shares of 87,989 Privia Health Group, Inc. (NASDAQ:PRVA)

Trexquant Investment LP acquired a new stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 87,989 shares of the company's stock, valued at approximately $1,720,000. Trexquant Investment LP owned about 0.07% of Privia Health Group as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Benjamin Edwards Inc. boosted its position in Privia Health Group by 360.7% during the third quarter. Benjamin Edwards Inc. now owns 14,366 shares of the company's stock worth $262,000 after acquiring an additional 11,248 shares during the last quarter. Quarry LP increased its holdings in shares of Privia Health Group by 344.6% during the 3rd quarter. Quarry LP now owns 3,268 shares of the company's stock worth $60,000 after buying an additional 2,533 shares during the last quarter. XTX Topco Ltd acquired a new position in shares of Privia Health Group in the 3rd quarter valued at $182,000. Barclays PLC boosted its stake in Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company's stock worth $4,079,000 after buying an additional 158,188 shares during the period. Finally, Geode Capital Management LLC lifted its stake in Privia Health Group by 1.0% during the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company's stock worth $43,986,000 after purchasing an additional 23,178 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.

Insiders Place Their Bets

In other news, CFO David Mountcastle sold 5,630 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the transaction, the chief financial officer now directly owns 179,676 shares of the company's stock, valued at approximately $4,021,148.88. This represents a 3.04 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.20% of the stock is currently owned by corporate insiders.

Remove Ads

Privia Health Group Trading Down 0.5 %

NASDAQ PRVA traded down $0.11 on Monday, hitting $23.99. 68,413 shares of the stock traded hands, compared to its average volume of 784,817. The company has a market capitalization of $2.91 billion, a P/E ratio of 239.89, a price-to-earnings-growth ratio of 3.47 and a beta of 0.88. The stock has a 50-day moving average of $23.76 and a 200 day moving average of $21.51. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $26.13.

Analysts Set New Price Targets

Several research firms have weighed in on PRVA. Canaccord Genuity Group lifted their target price on Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research report on Friday, February 28th. Stephens restated an "overweight" rating and issued a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. JMP Securities set a $29.00 price target on shares of Privia Health Group in a research report on Friday, February 28th. Needham & Company LLC reaffirmed a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a research report on Thursday. Finally, Macquarie assumed coverage on Privia Health Group in a report on Monday, December 16th. They issued an "outperform" rating and a $25.00 target price for the company. One equities research analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $26.87.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.